Related references
Note: Only part of the references are listed.Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol
Lie Yun Kok et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2022)
Formulation of Cannabidiol in Colloidal Lipid Carriers
Nadine Monika Francke et al.
MOLECULES (2021)
Natural sesame oil is superior to pre-digested lipid formulations and purified triglycerides in promoting the intestinal lymphatic transport and systemic bioavailability of cannabidiol
Wanshan Feng et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)
Validity of cycloheximide chylomicron flow blocking method for the evaluation of lymphatic transport of drugs
Pavel Rysanek et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain
Barbara Stella et al.
DRUGS (2021)
Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis
Andreas Kerschbaumer et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
The effect of medium chain and long chain triglycerides incorporated in selfnano emulsifying drug delivery systems on oral absorption of cannabinoids in rats
Dvora Izgelov et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Intestinal Lymph Flow, and Lipid and Drug Transport Scale Allometrically From Pre-clinical Species to Humans
Natalie L. Trevaskis et al.
FRONTIERS IN PHYSIOLOGY (2020)
The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations
Valentina Franco et al.
CLINICAL PHARMACOKINETICS (2020)
Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications
Emilio Perucca et al.
CNS DRUGS (2020)
Lymphatic Transport of Drugs after Intestinal Absorption: Impact of Drug Formulation and Physicochemical Properties
Pavel Rysanek et al.
PHARMACEUTICAL RESEARCH (2020)
The endocannabinoid signaling pathway as an emerging target in pharmacotherapy, earmarking mitigation of destructive events in rheumatoid arthritis
Ishnoor Kaur et al.
LIFE SCIENCES (2020)
Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts
Torsten Lowin et al.
CELL DEATH & DISEASE (2020)
Anti-arthritic effect of β-caryophyllene and its ameliorative role on methotrexate and/or leflunomide-induced side effects in arthritic rats
Sawsan M. A. El-Sheikh et al.
LIFE SCIENCES (2019)
A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
Sophie A. Millar et al.
FRONTIERS IN PHARMACOLOGY (2018)
Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations
Sofia Ajeganova et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2017)
Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation
Atheer Zgair et al.
SCIENTIFIC REPORTS (2017)
Pharmacokinetic and behavioural profile of THC, CBD, and THC plus CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC
Tomas Hlozek et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
The Mesenteric Lymph Duct Cannulated Rat Model: Application to the Assessment of Intestinal Lymphatic Drug Transport
Natalie L. Trevaskis et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2015)
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour
Serena Deiana et al.
PSYCHOPHARMACOLOGY (2012)
Human cannabinoid pharmacokinetics
Marilyn A. Huestis
CHEMISTRY & BIODIVERSITY (2007)
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
Christopher J. H. Porter et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs
A Dahan et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Influence of the type of surfactant and the degree of dispersion on the lymphatic transport of halofantrine in conscious rats
DM Karpf et al.
PHARMACEUTICAL RESEARCH (2004)
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
AM Malfait et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
